We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





COVID-19 Fuelling Growth of In-Vitro Diagnostics Market and Creating Novel Opportunities for Players

By LabMedica International staff writers
Posted on 21 Aug 2020
The global in-vitro diagnostics market is projected to register a compound annual growth rate of 5.60% from USD 55 billion in 2016 to nearly USD 90 billion by 2025, fueled by the massive rise in COVID -19 infections which is driving an increase in research and development activities in the diagnosis of infectious diseases. More...


These are the latest findings of Transparency Market Research (Albany, NY, USA), a market intelligence provider.

A slew of factors such as positive transformations in the medical and healthcare industries are expected to further support the market growth. Digital transformation, technological advancements and increasing significance of point-of-care diagnostics are contributing to the growth of the global in-vitro diagnostics market. State-of-the-art diagnostic facilities are enabling market growth by paving the way for better outcomes. More and more facilities are exploring advanced technologies for up-gradation purposes, thereby driving the demand for in-vitro diagnostics. Additionally, a notable increase in the incidence of cancer in several regions across the world will also contribute to the growth of the global in-vitro diagnostics market.

Furthermore, the rising incidence of infectious diseases, such as COVID-19, will act as a key driver for the growth of the global in-vitro diagnostics market. There has been an increase in the number of COVID-19 cases which is driving the demand for in-vitro diagnostic tests. The outbreak of the COVID-19 pandemic has led to investments in new research lines for diagnostic and treatment of infectious diseases. The medical industry has witnessed some success in developing diagnostic technologies for COVID-19, but still has a long way to go. As new research lines emerge for the management of the COVID-19 pandemic, the global in-vitro diagnostics market will continue to grow at a fast pace.

Geographically, the North American region is witnessing a massive increase in in-vitro testing which can be majorly attributed to the increase in COVID-19 cases in the US. In the Asia Pacific (APAC) region, cooperation between countries for better managing the increasing incidence of diseases is leading to the growth of the in-vitro diagnostics market. Rising cases of lung disorders and cancer is also supporting the market growth in several regions of the Asia Pacific.

Related Links:

Transparency Market Research


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Serological Pipet Controller
PIPETBOY GENIUS
New
Host Response Immunoassay Test
MeMed BV
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.